Market Access and Pricing

PharmaLex Merges with NeoHealthHub

October 13, 2022

Agreement featuring UK pharma services consultancy intends to grow PharmaLex's pan-European market access presence

Betting the House on Orphan Drugs

October 07, 2022

While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards